This inventor holds 1 USPTO granted patent. Top assignee: Universität Zu Koln. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Innovations by Benedikt Ostendorf in Diagnosing Degenerative Diseases
Introduction
Benedikt Ostendorf is a notable inventor based in Neuss, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the detection of autoantibodies related to degenerative diseases of the skeletal system. His work aims to improve the diagnosis and treatment of conditions such as arthritis.
Latest Patents
Ostendorf holds a patent for the "Detection of autoantibodies for diagnosing degenerative diseases of the skeletal system." This patent includes methods, kits, and active ingredients for diagnosing or treating arthritis or degenerative diseases of the skeletal system. The methods involve detecting an autoantibody associated with arthritis or excluding the presence of an autoantibody against collagen II. Additionally, the methods for diagnosing degenerative diseases involve detecting an autoantibody against thrombospondin-4 or COMP. The kits developed contain a detection agent for an autoantibody and can be utilized for diagnosing arthritis or degenerative diseases of the skeletal system. The active ingredient can be used for treating or preventing autoimmune-associated arthritis. Ostendorf has 1 patent to his name.
Career Highlights
Benedikt Ostendorf is affiliated with the University of Cologne, where he continues to advance his research in medical diagnostics. His work has the potential to significantly impact the way degenerative diseases are diagnosed and treated, providing new avenues for patient care.
Collaborations
Ostendorf collaborates with esteemed colleagues such as Andreas R Klatt and Johannes Ruthard, contributing to a rich environment of innovation and research.
Conclusion
Benedikt Ostendorf's contributions to the field of medical diagnostics exemplify the importance of innovation in improving healthcare outcomes. His patent for detecting autoantibodies represents a significant advancement in diagnosing degenerative diseases of the skeletal system.